The page is the record's research on the issuer — no analyst, no rating, no view. # Tiziana Life Sciences Ltd (NASDAQ: TLSA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Tiziana Life Sciences Ltd, listed on NASDAQ under ticker TLSA, with ISIN USG889121038. Its LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-D0. Its security type is non-operating entity type (other), its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is Bermuda. Its listing status is listed, not halted. ## The disclosure read The record holds 60 filings in the window 2025-11-08 to 2026-11-08, across 48 filing days. Of these, 40 are results, 10 are directors' dealings, 7 are regulatory filings and 3 are prospectuses. The median gap between filing days is 5 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date of 2026-11-08. The NASDAQ peer median is 6.0 days cadence and 5.0 days latency across 4,359 issuers, with a median of 52 filings. The 2834 Pharmaceutical Preparations peer median is 6.0 days cadence and 4.0 days latency across 526 issuers, with a median of 63.0 filings. ## Auditor The auditor is not on the record, as the latest annual report cover carries no dei:AuditorName tag, and foreign private issuers and older filings carry none. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page, the count is 0. ## Open research No openly published research notes were found, the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001723069.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/TLSA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/TLSA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/TLSA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp